Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA009945-01A1
Application #
2123383
Study Section
Special Emphasis Panel (SRCD (08))
Project Start
1996-06-15
Project End
1999-04-30
Budget Start
1996-06-15
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Heimer, Robert (2008) Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange. Int J Drug Policy 19 Suppl 1:S65-73
Heimer, Robert; Kinzly, Mark L; He, Helen et al. (2007) The effect of acids on the survival of HIV during drug injection. J Acquir Immune Defic Syndr 45:144-50
Abdala, Nadia; Crowe, Michelle; Tolstov, Yanis et al. (2004) Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions. Subst Use Misuse 39:581-600
Kyriakides, T C; Heimer, R R (2001) Development and application of a genotypic AZT resistance assay: quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index. J Acquir Immune Defic Syndr 28:211-20
Abdala, N; Gleghorn, A A; Carney, J M et al. (2001) Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users. J Acquir Immune Defic Syndr 28:487-94
Heimer, R; Abdala, N (2000) Viability of HIV-1 in syringes: implications for interventions among injection drug users. AIDS Read 10:410-7
Abdala, N; Reyes, R; Carney, J M et al. (2000) Survival of HIV-1 in syringes: effects of temperature during storage. Subst Use Misuse 35:1369-83
Abdala, N; Stephens, P C; Griffith, B P et al. (1999) Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol 20:73-80
Clatts, M C; Heimer, R; Abdala, N et al. (1999) HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1. J Acquir Immune Defic Syndr 22:194-9
Rich, J D; Dickinson, B P; Carney, J M et al. (1998) Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection. AIDS 12:2345-50